First Round of Abstract Submission Ends: Jan 30, 2025
Extended Early Bird Ends: Aug 20, 2024

Plenary Speakers

Prof. Yuan-Ting Zhang
Chinese University of Hong Kong, Hong Kong
Title: Health Engineering: from Tonoarteriography to Intelligent Systems for Hypertension and CVD Screening
Yuan-Ting Zhang is currently a Professor in the Department of Electronic Engineering at the Chinese University of Hong Kong, Visiting Professor at Oxford Suzhou Centre for Advanced Research (OSCAR), a MWLC-LRG member of Karolinska Institutet, Chief Scientist/Advisor in unobtrusive blood pressure measuring technology at the Shenzhen Honor Mobile Terminal LtD, the Chief Scientist of Guangdong Medical University, and the founding Chairman and Director of Hong Kong Center for Cerebrocardiovascular Health Engineering under the InnoHK clusters. He served as the Sensing System Architect in Health Technology and Sensing Hardware Divisions at Apple Inc., California, USA, the founding Director of the Key Lab for Health Informatics of Chinese Academy of Sciences (CAS), the founding Director of CAS-SIAT Institute of Biomedical and Health Engineering, Chair Professor at CityU, and Adjunct Chair Professor at Shandong University. Professor Zhang dedicated his service to the Chinese University of Hong Kong from 1994 to 2015, where he served as the first Head of the Division of Biomedical Engineering and led the efforts on establishing educational degree Programmes in Biomedical Engineering. Professor Zhang has been the Chair of the IEEE 1708 Standard Working Group for developing an international standard on Wearable Cuffless BP Measuring Devices since 2007 and became recently a member of European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability and a member of ISO Working Group on cuffless BP devices. He serves currently as Editor-in-Chief (EiC) for Connected Health and Telemedicine (CHATmed) starting in 2023. He was the EiC for IEEE T-ITB, the founding EiC of IEEE J-BHI, and the EiC for IEEE R-BME. He served as Vice President of IEEE EMBS, the Chair of 2016-2018 IEEE Award Committee in Biomedical Engineering, a member of IEEE Medal Panel for Healthcare Technology Award, and the award committee of IAMBE. He has been the main organizer for 22 editions of the Annual IEEE EMBS Summer School and Symposium on Medical Devices and Biosensors (MDBS) since 2002. Professor Zhang served as Technical Program Chair of EMBC’98 in Hong Kong, Conference Chair of EMBC’05 in Shanghai, International Committee Co-Chair of EMBC’07 in Lyon, International Committee Chair of EMBC’ 11 in Boston, International Committee Chair of EMBC’13 in Osaka, and Technical Program Committee Co-Chair of EMBC’17 in Jeju Island. He was invited to give numerous talks at various international conferences worldwide including those at the First IEEE Life Sciences Grand Challenges Conference held at the National Academy ofSciences in Washington DC in 2012, at the 40th IEEE-EMBS Annual International Conference (EMBC’18) in Hawaii in 2018, Earl Owen Lecture at SMIT-IBEC2018 in Korea, and at the 2019 Conference on Wearable Devices for Medical Diagnosis held at IIT in Israel. Professor Zhang's research interests include unobtrusive sensing, wearable devices, tonoarteriography/cBP, and neural physiological modeling. He was selected on the lists of China’s Most Cited Researchers in Biomedical Engineering by Elsevier, the top 2% researcher worldwide by Stanford University, and ranked No. 1 researcher in cuffless BP technology during the last 30 years from 1990 to 2020. He won a number of national and international awards including IEEE-EMBS best journal paper awards, IEEE-EMBS Outstanding Service Award, IEEE-SA 2014 Emerging Technology Award, IEEE-EMBS Chapter Award in Greece, Asia-Pacific E-Medicine Technology Grand Award in Australia, Earl Owen Lecture at SMITIBEC2018 in Korea, and most recently he won the 2023 IEEE EMBS William J. Morlock Award. Prof. Zhang is elected as IAMBE Fellow, IEEE Fellow, AIMBE Fellow and AAIA Fellow for his contributions to the development of wearable and mHealth technologies. Processor Zhang completed his undergraduate studies and master degree in the area of telecommunications at Shandong University and PhD in electrical and computer engineering with specialization in biomedical engineering at University of New Brunswick, Canada.
Prof. Guo-Wei HE
Tianjin University, China
Title: Proteomics and metabolomics studies and biomarkers of malignant ventricular arrhythmia associated with the acute myocardial infarction and atrial fibrillation
Professor Guo-Wei HE, MD, PhD, DSc, is Distinguished Professor of Tianjin University, China and Academician (Foreign Correspondence Member) at The National Academy of Medicine, France (2019-). Professor He is Vice President & Senior Cardiac Surgeon at TEDA International Cardiovascular Hospital, Tianjin University and Director of Institute for Cardiovasc Diseases, Tianjin University & Chinese Academy of Medical Sciences. He also holds Clinical Professor of Surgery at Oregon Health & Science University, Portland, OR, USA (2003-). In addition, Professor He is Director, Branch Center for National Clinical Research Center for Cardiovascular Disease and Director of Tianjin Key Laboratory for Molecular Regulation and Translational Medicine of Cardiovascular Diseases. He obtained Doctor of Science (2003) and Ph. D.(1989) from Monash University, Melbourne, Australia. Professor He was Chair Professor of Cardiothoracic Surgery, University of Hong Kong, 1995-2000 and Research Chair Professor, Chinese University of Hong Kong (2000-2009). Professor He was Director of Cardiovasc Res Lab, St, Vincent Hospital, Portland, OR, U.S.A. (1994-2012). Professor He is an active cardiac surgeon and he performed about 8,000 open heart operations. Notably, he is the first surgeon performing radial artery plus internal mammary artery in CABG at University of Hong Kong in Asia (1995) and is well known for “He Classification” and “He solutions” for CABG grafts. Apart from clinical practice, he is an active research and obtained more than 80 research grants and awards such as First Class Award, Tianjin Municipal Natural Science Award (2012), First Class Award, Prize of Science & Technology, The China Medicine Education Association (2021), exec. He published 416 articles/reports in SCI-index international journals. He ranked in World's Top 2% Scientists (1999-2023) by Stanford University with Google scholar citation > 11,000 and H-index of 56. Professor He ranks world’s Top 1% in Medicine, Chemistry, Genetics and Molecular Biology; He is Highly-cited Chinese Scholar in Clinical Medicine (2024). The top 0.05% of all scholars worldwide (ScholarGPS).
Prof. Kullervo Hynynen
Sunnybrook Research Institute, Canada

Noninvasive treatments using acoustic waves


Dr. Hynynen received his Ph.D. from the University of Aberdeen, UK. He accepted a faculty position at the University of Arizona. He joined the faculty at the Harvard University, and Brigham and Women’s Hospital in Boston, 1993. In 2006 he was recruited to Sunnybrook Research Institute as a Senior Scientist and the Director of Physical Sciences Platform. In January 2020, he assumed the position of Vice-President, Research and Innovation at Sunnybrook. He is a professor at the Medical Biophysics Department at University of Toronto. Dr. Hynynen has published over 450 peer reviewed papers on basic and clinical research related to ultrasound therapy. He has been the recipient of numerous research grants and contracts and has founded two companies. He is also a founder and Scientific director of INOVAIT a Canada wide network providing training, networking and funding to promote the use of AI in image-guided therapy.